Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
1.
Neurochem Int ; 175: 105706, 2024 May.
Article in English | MEDLINE | ID: mdl-38423391

ABSTRACT

Alcohol use disorder (AUD) is characterized by a set of behavioral, cognitive, nutritional, and physiological phenomena derived from the uncontrolled use of alcoholic beverages. There are cases in which AUD is associated with anxiety disorder, and when untreated, it requires careful pharmacotherapy. Blue Calm® (BC) is a food supplement indicated to aid restorative sleep, which has traces of medicinal plant extracts, as well as myo-inositol, magnesium bisglycinate, taurine, and L-tryptophan as its main chemical constituents. In this context, this study aimed to evaluate the potential of the BC in the treatment alcohol withdrawal-induced anxiety in adult zebrafish (aZF). Initially, BC was submitted to antioxidant activity against 2,2-diphenyl-1-picrylhydrazyl radical. Subsequently, the aZF (n = 6/group) were treated with BC (0.1 or 1 or 10 mg/mL; 20 µL; p.o.), and the sedative effect and acute toxicity (96 h) were evaluated. Then, the anxiolytic-like effect and the possible GABAergic mechanism were analyzed through the Light & Dark Test. Finally, BC action was evaluated for treating alcohol withdrawal-induced anxiety in aZF. Molecular docking was performed to evaluate the interaction of the major chemical constituents of BC with the GABAA receptor. BC showed antioxidant potential, a sedative effect, was not toxic, and all doses of BC had an anxiolytic-like effect and showed potential for the treatment of alcohol withdrawal-induced anxiety in aZF. In addition to the anxiolytic action, the main chemical constituents of BC were confirmed in the molecular docking, thus suggesting that BC is an anxiolytic that modulates the GABAergic system and has pharmacological potential for the treatment of alcohol withdrawal-induced anxiety.


Subject(s)
Alcoholism , Anti-Anxiety Agents , Substance Withdrawal Syndrome , Animals , Zebrafish/physiology , Anti-Anxiety Agents/pharmacology , Anti-Anxiety Agents/therapeutic use , Anxiety/chemically induced , Anxiety/drug therapy , Anxiety/psychology , Alcoholism/drug therapy , Molecular Docking Simulation , Substance Withdrawal Syndrome/drug therapy , Receptors, GABA-A , Antioxidants/pharmacology , Antioxidants/therapeutic use , Anxiety Disorders/drug therapy , Dietary Supplements , Hypnotics and Sedatives
2.
Biochem Biophys Rep ; 37: 101598, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38075000

ABSTRACT

Bromelain, the main protease enzyme found in the pineapple plant (Ananas comosus), has had its antinociceptive effect previously demonstrated. This investigation aimed to appraise the role of TRP (Transient Receptor Potential) channels in the nociception-relieving effects of bromelain in the orofacial region of adult zebrafish. The animals were pretreated with bromelain (3.0, 10.0 or 30.0 mg/mL; gavage) and submitted to open field and acute orofacial (capsaicin - TRPV1 agonist, cinnamaldehyde - TRPA1 agonist or menthol - TRPM8 agonist) nociception tests. The investigation also explored the contribution of central afferent C-fibers. Naive groups were included for comparison. Bromelain did not independently affect the zebrafish movement patterns. However, bromelain decreased the nociceptive responses elicited by all three TRP channel activators. Capsazepine (TRPV1 inhibitor) and AMTB (TRPM8 inhibitor), but not HC-030031 (TRPA1 inhibitor), prevented the antinociceptive effect of bromelain. Moreover, capsaicin-induced desensitization effectively nullified the antinociceptive effect of bromelain. Collectively, these findings corroborate the therapeutic relevance of bromelain as a suppressor of orofacial nociception, which seems to be intricately connected to the modulation of TRP channels.

3.
BrJP ; 6(2): 134-138, Apr.-June 2023. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1513779

ABSTRACT

ABSTRACT BACKGROUND AND OBJECTIVES: Chronic postoperative pain (CPP) can be defined as pain that continues for two or more months after surgery, after ruling out other causes. In Brazil, there is a lack of reliable data regarding the incidence of acute and chronic postoperative pain, as well as its impact on patients. The aim of this study was to evaluate the knowledge of anesthesiologists and surgeons regarding the management of CPP. METHODS: This cross-sectional observational study was conducted using an online questionnaire distributed to a non-probabilistic convenience sample of anesthesiologists and surgeons. The questionnaire, administered through Google Forms™, consisted of 22 questions covering sociodemographic information, self-assessment of knowledge, therapeutic management of postoperative pain, and the perceived need for further training. Chi-square test or Fisher's Exact test was used to analyze the data. RESULTS: The main sociodemographic findings indicate a gender difference (p=0.03) among surgeons. Of 109 participants, most did not have expertise or specialization in pain management (p=0.02) and obtained knowledge about pain and analgesia only after undergraduate courses (p=0.013). Surgeons provided more incorrect answers about the definition of acute pain (p<0.001) and chronic pain (p=0.003) than anesthesiologists. Most participants claim to remember at least two risk factors for the development of chronic pain in surgical patients (p=0.001). Participants did not recommend the use of antidepressants (p=0.024) or antiepileptics (p=0.013) for the treatment of acute pain. Anesthesiologists considered strong opioids adequate to control acute pain (p<0.001). In relation to chronic pain, 70.7% of surgeons and 89.7% of anesthesiologists believed that antiepileptic drugs could be effective in managing this type of pain (p=0.018). Longer training time was related to less study of pain during undergraduate education (p=0.041). CONCLUSION: Surgeons and anesthesiologists showed substantial deficits in knowledge about postoperative pain. It is necessary to reassess the inclusion of the pain subject in medical curricula, and a more practical approach to the topic could greatly benefit future professionals working in this field.


RESUMO JUSTIFICATIVA E OBJETIVOS: A dor pós-operatória crônica (DPC) pode ser definida como uma dor que persiste por dois ou mais meses após a cirurgia, após a exclusão de outras causas. No Brasil, faltam dados confiáveis sobre a incidência de dor pós-operatória aguda e crônica, bem como seu impacto nos pacientes. O objetivo deste estudo foi avaliar o conhecimento de anestesiologistas e cirurgiões sobre o manejo da DPC. MÉTODOS: Este estudo observacional transversal foi realizado por meio de um questionário online distribuído a uma amostra não probabilística de conveniência de anestesiologistas e cirurgiões. O questionário, administrado por meio do Google Forms™, consistia em 22 questões abrangendo informações sociodemográficas, autoavaliação do conhecimento, manejo terapêutico da dor pós-operatória e percepção da necessidade de treinamento adicional. O teste Qui-quadrado ou o Exato de Fisher foi utilizado para analisar os dados. RESULTADOS: Os principais achados sociodemográficos indicaram diferença de sexo (p=0,03) entre os cirurgiões. Dos 109 participantes, a maioria não possuía expertise ou especialização no manejo da dor (p=0,02) e obtiveram conhecimento sobre dor e analgesia somente após a graduação (p=0,013). Os cirurgiões forneceram mais respostas incorretas sobre a definição de dor aguda (p<0,001) e dor crônica (p=0,003) do que os anestesiologistas. A maioria dos participantes afirmou se lembrar de ao menos dois fatores de risco para o desenvolvimento de dor crônica em pacientes cirúrgicos (p=0,001). Os participantes não recomendaram o uso de antidepressivos (p=0,024) ou antiepilépticos (p=0,013) para o tratamento da dor aguda. Os anestesiologistas consideraram os opioides fortes adequados para o controle da dor aguda (p<0,001). Em relação à dor crônica, 70,7% dos cirurgiões e 89,7% dos anestesiologistas acreditam que os fármacos antiepilépticos podem ser eficazes no controle desse tipo de dor (p=0,018). O maior tempo de formação foi relacionado a um menor estudo da dor durante a graduação (p=0,041). CONCLUSÃO: Cirurgiões e anestesiologistas mostraram déficits substanciais no conhecimento sobre dor pós-operatória. É preciso reavaliar a inclusão do tema da dor nos currículos médicos, e uma abordagem mais prática do tema pode beneficiar muito os futuros profissionais que atuam nessa área.

4.
Physiol Behav ; 269: 114238, 2023 10 01.
Article in English | MEDLINE | ID: mdl-37207745

ABSTRACT

Melatonin is an endogenous hormone, known as the sleep hormone, which has already demonstrated its antinociceptive effect. This study aimed to evaluate the participation of TRP's channels in the orofacial antinociceptive effect of melatonin (MT) in adult zebrafish. Initially, the open field test was performed to evaluate the effect of MT on the locomotor activity of adult zebrafish. Then, the animals were pre-treated with MT (0.1, 0.3 or 1 mg/mL; gavage) and acute orofacial nociception was induced by the application of capsaicin (TRPV1 agonist), cinnamaldehyde (TRPA1 agonist) or menthol (TRPM8 agonist) applied into the animal's lip. Naive groups were included. MT, per se, did not alter the locomotor activity of the animals. MT reduced the nociceptive behavior induced by the three agonists; however, the most significant effect was obtained with the lowest concentration tested (0.1 mg/mL) in the capsaicin test. The orofacial antinociceptive effect of melatonin was prevented by capsazepine (TRPV1 antagonist), but not by HC-030031 (TRPA1 antagonist). The molecular docking study indicated interaction between MT and the TRPV1, TRPA1 and TRPM8 channels and, in line with the in vivo results, there was greater affinity between MT and the TRPV1 channel. The results confirm the pharmacological relevance of melatonin as an inhibitor of orofacial nociception and this effect seems to be related to the modulation of TRP's channels.


Subject(s)
Melatonin , TRPM Cation Channels , Animals , Zebrafish , Analgesics/pharmacology , Analgesics/therapeutic use , Capsaicin/pharmacology , Melatonin/pharmacology , TRPV Cation Channels , Molecular Docking Simulation , TRPA1 Cation Channel
5.
Geroscience ; 45(4): 2121-2133, 2023 Aug.
Article in English | MEDLINE | ID: mdl-36913129

ABSTRACT

Ovarian reserve is a term used to estimate the total number of immature follicles present in the ovaries. Between birth and menopause, there is a progressive decrease in the number of ovarian follicles. Ovarian aging is a continuous physiological phenomenon, with menopause being the clinical mark of the end of ovarian function. Genetics, measured as family history for age at the onset of menopause, is the main determinant. However, physical activity, diet, and lifestyle are important factors that can influence the age of menopause. The low estrogen levels after natural or premature menopause increased the risk for several diseases, resulting in increased mortality risk. Besides that, the decreasing ovarian reserve is associated to reduced fertility. In women with infertility undergoing in vitro fertilization, reduced markers of ovarian reserve, including antral follicular count and anti-Mullerian hormone, are the main indicators of reduced chances of becoming pregnant. Therefore, it becomes clear that the ovarian reserve has a central role in women's life, affecting fertility early in life and overall health later in life. Based on this, the ideal strategy for delaying ovarian aging should have the following characteristics: (1) be initiated in the presence of good ovarian reserve; (2) maintained for a long period; (3) have an action on the dynamics of primordial follicles, controlling the rate of activation and atresia; and (4) safe use in pre-conception, pregnancy, and lactation. In this review, we therefore discuss some of these strategies and its feasibility for preventing a decline in the ovarian reserve.


Subject(s)
Longevity , Ovary , Pregnancy , Humans , Female , Ovary/physiology , Reproduction/physiology , Aging/physiology , Fertility/physiology
6.
Planta Med ; 89(5): 539-550, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36720229

ABSTRACT

This study evaluates the pharmacological potential of cis-jasmone (CJ) in adult zebrafish (Danio rerio; aZF). Initially, aZF (n = 6/group) were pretreated (20 µL; p. o.) with CJ (0.1 or 0.3 or 1.0 mg/mL) or vehicle (0.5% Tween 80). The animals were submitted to acute toxicity and locomotion tests, pentylenetetrazole-induced seizure, carrageenan-induced abdominal edema, and cinnamaldehyde-, capsaicin-, menthol-, glutamate-, and acid saline-induced orofacial nociception. The possible mechanisms of anticonvulsant, anxiolytic, and antinociceptive action were evaluated. The involvement of central afferent fibers sensitive to cinnamaldehyde and capsaicin and the effect of CJ on the relative gene expression of TRPA1 and TRPV1 in the brain of aZF were also analyzed, in addition to the study of molecular docking between CJ and TRPA1, TRPV1 channels, and GABAA receptors. CJ did not alter the locomotor behavior and showed pharmacological potential in all tested models with no toxicity. The anticonvulsant effect of CJ was prevented by flumazenil (GABAergic antagonist). The anxiolytic-like effect of CJ was prevented by flumazenil and serotonergic antagonists. The antinociceptive effect was prevented by TRPA1 and TRPV1 antagonists. Chemical ablation with capsaicin and cinnamaldehyde prevented the orofacial antinociceptive effect of CJ. Molecular docking studies indicate that CJ interacted with TRPA1, TRPV1, and GABAA receptors. CJ inhibited the relative gene expression of TRPA1 and TRPV1. CJ has pharmacological potential for the treatment of seizures, anxiety, inflammation, and acute orofacial nociception. These effects are obtained by modulating the GABAergic and serotonergic systems, as well as the TRPs and ASIC channels.


Subject(s)
Analgesics , Anti-Anxiety Agents , Animals , Analgesics/pharmacology , Analgesics/therapeutic use , Zebrafish/metabolism , Capsaicin/pharmacology , Molecular Docking Simulation , Anticonvulsants/pharmacology , Anticonvulsants/therapeutic use , Flumazenil , gamma-Aminobutyric Acid , TRPV Cation Channels/genetics , TRPV Cation Channels/metabolism
7.
Molecules ; 27(21)2022 Nov 03.
Article in English | MEDLINE | ID: mdl-36364332

ABSTRACT

Lectins are a heterogeneous group of proteins that reversibly bind to simple sugars or complex carbohydrates. The plant lectin purified from the seed of Parkia platycephala (PPL) was studied. This study aimed to investigate the possible orofacial antinociceptive of PPL lectin in adult zebrafish and rodents. Acute nociception was induced by cinnamaldehyde (0.66 µg/mL), 0.1% acidified saline, glutamate (12.5 µM) or hypertonic saline (5 M NaCl) applied into the upper lip (5.0 µL) of adult wild zebrafish. Zebrafish were pretreated by intraperitoneal injection (20 µL) with vehicle (Control) or PPL (0.025; 0.05 or 0.1 mg/mL) 30 min before induction. The effect of PPL on zebrafish locomotor behaviour was evaluated in the open field test. Naive groups were included in all tests. In one experiment, animals were pre-treated with capsazepine to investigate the mechanism of antinociception. The involvement of central afferent C-fibres was also investigated. In another experiment, rats pre-treated with PPL or saline were submitted to the temporomandibular joint formalin test. Other groups of rats were submitted to infraorbital nerve transection to induce chronic pain, followed by induction of mechanical sensitivity using von Frey. PPL reduced nociceptive behaviour in adult zebrafish, and this is related to the activation of the TRPV1 channels since antinociception was effectively inhibited by capsazepine and by capsaicin-induced desensitization. PPL reduced nociceptive behaviour associated with temporomandibular joint and neuropathic pain. The results confirm the potential pharmacological relevance of PPL as an inhibitor of orofacial nociception in acute and chronic pain.


Subject(s)
Chronic Pain , Fabaceae , Rats , Animals , Nociception , Zebrafish/metabolism , Analgesics/pharmacology , Analgesics/therapeutic use , Facial Pain/drug therapy , Facial Pain/metabolism , Lectins/metabolism , Chronic Pain/drug therapy , Fabaceae/metabolism , Rodentia/metabolism , TRPV Cation Channels/metabolism , Zebrafish Proteins/metabolism
8.
J Epilepsy Res ; 12(1): 1-5, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35910324

ABSTRACT

Background and Purpose: The literature is still controversial in relation to therapeutic differences between innovative, generic, and similar anti-seizures medications (ASM). Topiramate (TPM) is an ASM used in the treatment of various seizure types and in different epileptic syndromes, as well as in other groups of morbidities, and it is available in many generic and similar forms, besides the innovator. The aim of this translational work was to compare different brands of TPM by using animal models of seizures induced by pentylenetetrazole (PTZ). Methods: Five brands of TPM (one reference, two similar and two generics) were tested in mice. Animals were previously treated with TPM (n=6/brand) and latencies from PTZ injection to onset of manifestations, first seizure and death were measured and compared between groups. Experiment was conducted in two settings: acute seizure model (PTZ 80 mg/kg) and kindling model (PTZ 20, 30, and 40 mg/kg in 8 alternate days). Results: The experiment did not demonstrate significant differences between the TPM brands regarding the protective effect in the acute seizure and kindling models. Conclusions: In conclusion, results can be explained by true therapeutic equivalence or insufficiency of the PTZ model to reveal differences among brands.

9.
AAPS PharmSciTech ; 23(7): 239, 2022 Aug 25.
Article in English | MEDLINE | ID: mdl-36002707

ABSTRACT

Nanoencapsulation is a valid alternative for the oral administration of peptide drugs and proteins, as nanoparticles protect them from proteolytic degradation in the gastrointestinal tract and promote the absorption of these macromolecules. The orofacial antinociceptive effect of frutalin (FTL), through the intraperitoneal route, has already been proven. This study aimed to develop, characterize, and evaluate the orofacial antinociceptive activity of an oral formulation containing FTL in acute and neuropathic preclinical tests. Nanoencapsulated FTL was administered by oral route. The acute nociceptive behavior was induced by administering capsaicin to the upper lip and NaCl to the right cornea. The nociceptive behavior was also induced by formalin injected into the temporomandibular joint. The neuropathic pain model involved infraorbital nerve transection (IONX), which induced mechanical hypersensitivity and was assessed by von Frey stimulation. Trpv1 gene expression was analyzed in the trigeminal ganglion. The analyzed sample did not show any cytotoxicity; 52.2% of the FTL was encapsulated, and the size of the nanocapsule was less than 200 nm, the polydispersion was 0.361, and the zeta potential was - 5.87 and - 12.8 mV, with and without FTL, respectively. Nanoencapsulated FTL administered by oral route had an orofacial antinociceptive effect in acute and neuropathic rodent models. The antinociceptive effect of FTL was prevented by ruthenium red, but not by camphor. FTL reduced Trpv1 gene expression. FTL promotes orofacial antinociception, probably due to the antagonism of TRPV1 channels, and the nanoformulation represents an effective method for the oral administration of this protein. HIGHLIGHTS: • Nanoformulation for oral protein administration. • Nanocapsule containing FTL prevents orofacial nociceptive acute and neuropathic pain. • Frutalin promotes orofacial antinociception behavior antagonism of TRPV1 channels.


Subject(s)
Nanocapsules , Neuralgia , Administration, Oral , Analgesics , Animals , Disease Models, Animal , Facial Pain/drug therapy , Facial Pain/metabolism , Nociception/physiology
10.
CNS Neurol Disord Drug Targets ; 21(1): 95-103, 2022.
Article in English | MEDLINE | ID: mdl-33583388

ABSTRACT

BACKGROUND: Plant lectins have shown promising neuropharmacological activities in animal models. OBJECTIVE: This study evaluated the effect of Dioclea altissima seed lectin (DAL) on adult zebrafish behavior. METHOD: Zebrafish (n=6/group) were treated (i.p.; 20 µL) with DAL (0.025; 0.05 or 0.1 mg/mL), vehicle or diazepam (DZP) and submitted to several tests (open field, light/dark preference or novel tank). Flumazenil, pizotifen or granisetron were administered 15 min before DAL (0.05 mg/mL), and the animals were evaluated on light/dark preference test. It was also verified whether the DAL effect depended on its structural integrity and ability to interact with carbohydrates. RESULTS: DAL decreased the locomotor activity of adult zebrafish (0.025; 0.05 or 0.1 mg/mL), increased the time spent in the upper region of the aquarium (0.025 mg/mL), and decreased the latency time of adult zebrafish to enter the upper region on the novel tank test. DAL (0.05 mg/mL) also increased their permanence in the light zone of the light/dark preference test. The effect of DAL was dependent on carbohydrate interaction and protein structure integrity and was prevented by pizotifen, granizetron and flumazenil. CONCLUSION: DAL was found to have an anxiolytic-like effect mediated by the 5-HT and GABAergic receptors.


Subject(s)
Anxiety/drug therapy , Behavior, Animal/drug effects , Dioclea/metabolism , Lectins/metabolism , Zebrafish/metabolism , Animals , Anti-Anxiety Agents/therapeutic use , Disease Models, Animal , Locomotion/drug effects , Motor Activity/drug effects , Receptors, GABA-A/metabolism , Seeds
11.
Physiol Behav ; 233: 113348, 2021 05 01.
Article in English | MEDLINE | ID: mdl-33545208

ABSTRACT

There is a discussion about the impact of technological development on behavioural aspects, a nuance that the present study aimed to assess. p21, p26 and p36 mice were subjected to audio (70 db) and visual stimulation (flashing lights) for 2 or 6 h per day until p64. Naive animals were included. From p74 onwards, the animals were subjected to tests to assess their locomotion, depression, anxiety, aggressiveness, and nociception behaviours. Weight assessment was also performed. The animals that received stimulation for 2 h a day since p21 showed a decrease in rearing and grooming behaviour in the open field test, as well as in the mechanical orofacial sensitivity. Animals that received stimulation for 6 h daily since p21 showed increased locomotor activity in the open field test. Animals that received stimulation for 2 h a day since p26 showed an increase in locomotor activity and a decrease in grooming behaviour in the open field test, in addition to a reduction in the number of entries in the closed arm of the elevated plus maze. Animals stimulated from p26 for 6 h daily increased the reaction time to the thermal stimulus. Animals that received stimulation for 2 h daily since p36 showed an increase in locomotor activity and a decrease in grooming behaviour in the open field test. Taken together, these findings suggest that audiovisual overstimulation during critical periods of brain development may have adverse effects compatible with hyperactivity in adulthood.


Subject(s)
Anxiety , Cognition , Animals , Behavior, Animal , Maze Learning , Mice , Photic Stimulation
12.
BrJP ; 4(1): 9-14, Jan.-Mar. 2021. graf
Article in English | LILACS-Express | LILACS | ID: biblio-1249135

ABSTRACT

ABSTRACT BACKGROUND AND OBJECTIVES: Adult zebrafish (Danio rerio) has been proposed as a low-cost and simple alternative to the use of rodents in laboratory research on novel compounds with antinociceptive potential. This study aimed to assess whether there is an influence of animal sex and the test environment on the orofacial nociceptive behavior of the adult zebrafish. METHODS: First, cinnamaldehyde, menthol, capsaicin, acidic saline, or glutamate was applied into the lips of the adult male or female zebrafish. Naive groups were included as control. The orofacial nociception was quantified in terms of locomotor activity. In other series of experiments, it was evaluated whether the apparatus, acclimatization, period of test, temperature of the water and color of the open field would alter the nociceptive response to cinnamaldehyde. RESULTS: The nociceptive behavior did not depend on the sex of the animal, apparatus, time the test was performed or the color of the open field. However, acclimatization promoted nociceptive behavior in naive animals and did not alter the nociceptive response to cinnamaldehyde (p<0.01 vs acclimatized naive). The nociception behavior was presented only when the test was performed at a temperature of 26ºC (p<0.01 vs naive). CONCLUSION: The results suggest the need to control the environment and water temperature as an environmental source of variation during the nociceptive behavior test of the adult zebrafish.


RESUMO JUSTIFICATIVA E OBJETIVOS: O peixe-zebra adulto (Danio rerio) tem sido proposto como uma alternativa simples e de baixo custo ao uso de roedores em pesquisas laboratoriais de novos compostos com potencial antinociceptivo. Este estudo teve como objetivo avaliar se há influência do sexo do animal e do ambiente de teste no comportamento nociceptivo orofacial do peixe-zebra adulto. MÉTODOS: Inicialmente, cinamaldeído, mentol, capsaicina, solução salina ácida ou glutamato foi aplicada nos lábios do peixe-zebra adulto masculino ou feminino. Grupos naive foram incluídos como controle. A nocicepção orofacial foi quantificada em termos de atividade locomotora. Em outra série de experimentos, foi avaliado se o aparato, aclimatação, período de teste, temperatura da água e cor do campo aberto alterariam a resposta nociceptiva ao cinamaldeído. RESULTADOS: O comportamento nociceptivo não dependeu do sexo do animal, do equipamento de teste, do horário em que o teste foi realizado ou da cor do campo aberto. No entanto, a aclimatação promoveu comportamento nociceptivo em animais naive e não alterou promoveu comportamento nociceptivo em animais naive e não alterou a resposta nociceptiva ao cinamaldeído (p<0,01 vs naive aclimatado). O comportamento nociceptivo foi verificado apenas quando o teste foi executado a uma temperatura de 26ºC (p<0,01 vs naive). CONCLUSÃO: Os resultados sugerem a necessidade de controlar o ambiente e a temperatura da água como fonte de variação ambiental durante o teste de comportamento nociceptivo do peixe-zebra adulto.

13.
Rev Soc Bras Med Trop ; 53: e20200657, 2020.
Article in English | MEDLINE | ID: mdl-33263691

ABSTRACT

INTRODUCTION: Quantitative reverse transcription polymerase chain reaction (RT-qPCR) can detect the severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) in a highly specific manner. However, a decrease in the specificity of PCR assays for their targets may lead to false negative results. METHODS: Here, 177 high-coverage complete SARS-CoV-2 genome sequences from 13 Brazilian states were aligned with 15 WHO recommended PCR assays. RESULTS: Only 3 of the 15 completely aligned to all Brazilian sequences. Ten assays had mismatches in up to 3 sequences and two in many sequences. CONCLUSION: These results should be taken into consideration when using PCR-based diagnostics in Brazil.


Subject(s)
COVID-19/virology , Genome, Viral , SARS-CoV-2/genetics , Brazil , Computer Simulation , Humans , Pandemics , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity
14.
Biochem Biophys Res Commun ; 533(3): 362-367, 2020 12 10.
Article in English | MEDLINE | ID: mdl-32962857

ABSTRACT

Drugs used to treat pain are associated with adverse effects, increasing the search for new drugs as an alternative treatment for pain. Therefore, we evaluated the antinociceptive behavior and possible neuromodulation mechanisms of triterpene 3ß, 6ß, 16ß-trihydroxylup-20(29)-ene (CLF-1) isolated from Combretum leprosum leaves in zebrafish. Zebrafish (n = 6/group) were pretreated with CLF-1 (0.1 or 0.3 or 1.0 mg/mL; i.p.) and underwent nociception behavior tests. The antinociceptive effect of CFL-1 was tested for modulation by opioid (naloxone), nitrergic (L-NAME), nitric oxide and guanylate cyclase synthesis inhibitor (methylene blue), NMDA (Ketamine), TRPV1 (ruthenium red), TRPA1 (camphor), or ASIC (amiloride) antagonists. The corneal antinociceptive effect of CFL-1 was tested for modulation by TRPV1 (capsazepine). The effect of CFL-1 on zebrafish locomotor behavior was evaluated with the open field test. The acute toxicity study was conducted. CLF-1 reduced nociceptive behavior and corneal in zebrafish without mortalities and without altering the animals' locomotion. Thus, CFL-1 presenting pharmacological potential for the treatment of acute pain and corneal pain, and this effect is modulated by the opioids, nitrergic system, NMDA receptors and TRP and ASIC channels.


Subject(s)
Analgesics/pharmacology , Combretum/chemistry , Locomotion/drug effects , Nociception/drug effects , Pain/prevention & control , Triterpenes/pharmacology , Acid Sensing Ion Channels/metabolism , Amiloride/pharmacology , Analgesics/isolation & purification , Animals , Camphor/pharmacology , Capsaicin/analogs & derivatives , Capsaicin/pharmacology , Dose-Response Relationship, Drug , Female , Ketamine/pharmacology , Locomotion/physiology , Male , Methylene Blue/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Naloxone/pharmacology , Nociception/physiology , Pain/metabolism , Pain/physiopathology , Pain Measurement , Plant Extracts/chemistry , Plant Leaves/chemistry , Receptors, N-Methyl-D-Aspartate/metabolism , Ruthenium Red/pharmacology , TRPV Cation Channels/metabolism , Triterpenes/isolation & purification , Zebrafish , Zebrafish Proteins/metabolism
15.
Int J Biol Macromol ; 161: 1079-1085, 2020 Oct 15.
Article in English | MEDLINE | ID: mdl-32561277

ABSTRACT

Lectins are proteins of non-immunological origin that may play several biological applications, of which we can highlight the anti-inflammatory and antinociceptive activities. In this work, we evaluated the possible effect of orofacial antinociceptive activity of three plant lectins, Dioclea violacea (DVL - Man/Glc-binding), Vatairea macrocarpa (VML - Gal-binding) and PPL (Parkia platycephala - Man/Glc-binding) in adult zebrafish. Acute nociception was induced by menthol (1.2 µM), or capsaicin (4.93 µM) applied into in the upper lip (5.0 µL) of adult wild zebrafish. Zebrafish were pretreated by intraperitoneal injection (20 µL) with vehicle (Control) or lectins (0.025; 0.05 or 0.1 mg/mL) 30 min before induction. The effect of lectins on zebrafish locomotor behavior was evaluated with the open field test. Naive groups (n = 8) were included in all tests. Our results indicate that only PPL presented antinociceptive induced by capsaicin, suggesting the potential clinical application of PPL as inhibitor of orofacial nociception and that this effect may be due to the modulation of TRPV1 channel. In conclusion, lectins that exhibit affinity to the same or different carbohydrates do not necessarily have an antinociceptive effect on the orofacial nociception model, indicating that the glycan carbohydrate binding pattern may be related to the effect on nociception inhibition.


Subject(s)
Lectins/chemistry , Lectins/pharmacology , Monosaccharides/chemistry , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Chemical Fractionation , Chromatography, Gel , Hemagglutination , Hemagglutination Tests , Lectins/isolation & purification , Vasoconstrictor Agents/chemistry , Vasoconstrictor Agents/pharmacology , Zebrafish
16.
Biochem Biophys Res Commun ; 526(2): 505-511, 2020 05 28.
Article in English | MEDLINE | ID: mdl-32241546

ABSTRACT

The action of anxiolytic compounds that act on selective serotonin receptors (SSRIs) have been scarcely evaluated. Serotonergic drugs have been shown to be effective in treating anxiety without presenting adverse effects as benzodiazepines. However, the anxiolytic effects take days to occur. This study aimed to evaluate the anxiolytic effect of the synthetic chalcone, 4'-[(2E) -3- (3-nitrophenyl) -1- (phenyl) prop-2-en-1-one] acetamide (PAAMNBA), and its possible mechanism of action in adult zebrafish (Danio rerio). PAAMNBA was synthesized with a yield of 51.3% and its chemical structure was determined by 1H and 13C NMR. Initially, PAAPMNBA was intraperitoneally administered to zebrafish (n = 6/group) at doses of 4, 12, or 40 mg/kg, and the animals were subsequently subjected to acute and open field toxicity tests. PAAMNBA was administered to the other groups (n = 6/group) for analyzing its effect in the light and dark test. The involvement of the serotonergic (5HT) system was also evaluated using 5-HTR 1, 5-HTR 2A/2C, and 5-HTR 3A/3B receptor antagonists, namely, pizotifeo, granizetron, and ciproeptadina, respectively. Molecular coupling was performed using the 5-HT1 receptor. PAAMNBA was found to be non-toxic, reduced the locomotor activity, and had an anxiolytic effect in adult zebrafish. The effect was reduced by pretreatment with pizotifene and was not reversed by treatment with granizetron and cyproeptadine. A previous in vivo molecular coupling study indicated that chalcones interact with the 5-HT1 receptor. The results suggested that the chalcone, PAAPMNBA, has anxiolytic activity, that is mediated by the serotonergic system via the 5-HT1 receptor. The interaction of PAAPMNBA with the 5-HT1 receptor was confirmed by molecular docking studies.


Subject(s)
Acetamides/pharmacology , Anti-Anxiety Agents/pharmacology , Chalcone/pharmacology , Serotonin/metabolism , Acetamides/chemistry , Animals , Anti-Anxiety Agents/chemistry , Anxiety/drug therapy , Anxiety/metabolism , Chalcone/analogs & derivatives , Drug Discovery , Locomotion/drug effects , Molecular Docking Simulation , Receptors, Serotonin, 5-HT1/metabolism , Zebrafish , Zebrafish Proteins/metabolism
17.
J Oral Facial Pain Headache ; 34(2): 174-186, 2020.
Article in English | MEDLINE | ID: mdl-32255583

ABSTRACT

AIMS: To test for the possible antinociceptive effect of nifedipine in rodent models of acute and chronic neuropathic orofacial pain and the possible involvement of TRP- and NMDA-related processes in this effect. METHODS: Acute nociceptive behavior was induced by administering formalin, cinnamaldehyde, glutamate, capsaicin, or acidified saline to the upper lip or hypertonic saline to the cornea of Swiss mice. Acute nociceptive behavior was also induced by formalin injected into the TMJ or mustard oil injected into the masseter muscle of Wistar rats. The chronic pain model involved infraorbital nerve transection (IONX) in Wistar rats to induce mechanical hypersensitivity, which was assessed with von Frey hair stimulation of the upper lip. The effects of pretreatment with nifedipine or vehicle (control) were tested on the nociceptive behaviors. Docking experiments were also performed. Statistical analysis included one-way ANOVA followed by Tukey post hoc test and two-way ANOVA followed by Bonferroni post hoc test (statistical significance P < .05). RESULTS: Nifedipine produced significant antinociceptive effects in all of the acute nociceptive behaviors except that induced by capsaicin. The antinociceptive effects were attenuated by NMDA, TRPA1, or TRPM3 receptor antagonists. The IONX animals developed facial mechanical hypersensitivity, which was significantly reduced by nifedipine. The docking experiments suggested that nifedipine may interact with TRPM3 and NMDA receptors. CONCLUSION: The present study has provided novel findings in a variety of acute and chronic orofacial pain models showing that nifedipine, a selective inhibitor of L-type Ca2+ channels, can suppress orofacial nociceptive behavior through NMDA, TRPA1, and TRPM3 receptor systems.


Subject(s)
Rodentia , TRPM Cation Channels , Analgesics , Animals , Facial Pain , Mice , N-Methylaspartate , Nifedipine , Rats , Rats, Wistar , TRPA1 Cation Channel
18.
Food Res Int ; 128: 108813, 2020 02.
Article in English | MEDLINE | ID: mdl-31955772

ABSTRACT

Several Passiflora species are known for their sedative and anxiolytic properties. However, the functional properties of Passiflora tenuifila Killip are still unexplored. The objective of this work was to evaluate the phenolic composition and acute toxicity, anxiolytic, sedative, and anticonvulsant effects using in vivo assays. The whole fruit (peel, pulp, and seed) was lyophilized and used for all assays. LC-MS showed 19 phenolic compounds, tentatively identified as flavonoids and phenolic acids. Acute treatment with single doses of up to 2000 mg kg-1 in Wistar rats showed no signs of mortality or toxicity over 14 days. The assay of functional effects was performed with Swiss mice, four groups, received by gavage, doses of P. tenuifila (200 or 400 mg kg-1 body weight), water, and diazepam (as negative and positive control), and behavior tests were performed after 60 min of the treatments. The animals treated with P. tenuifila fruit showed a significant decrease in locomotor activity, indicating a sedative and anxiolytic activity. No significant changes were observed in the rotarod apparatus, suggesting that the P. tenuifila fruit did not cause muscle relaxation. The 400 mg kg-1 dose of P. tenuifila exerted a protective effect against pentylenetetrazole-induced seizures, decreasing the severity and not causing the death of the animals. In conclusion, P. tenuifila showed no acute toxicity and had a promising effect as an anxiolytic agent, hypnotic-sedative and anticonvulsant, which could be related to its composition of flavonoids and phenolic acids.


Subject(s)
Anti-Anxiety Agents/pharmacology , Anticonvulsants/pharmacology , Antidepressive Agents/pharmacology , Fruit/chemistry , Passiflora/chemistry , Plant Extracts/pharmacology , Animals , Anti-Anxiety Agents/chemistry , Anticonvulsants/chemistry , Antidepressive Agents/chemistry , Anxiety/drug therapy , Behavior, Animal , Diazepam/pharmacology , Dose-Response Relationship, Drug , Fluoxetine/pharmacology , Mice , Motor Activity/drug effects , Pentylenetetrazole/toxicity , Plant Extracts/chemistry , Seizures/chemically induced , Seizures/drug therapy
19.
J Med Food ; 23(2): 173-180, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31502908

ABSTRACT

Studies involving foods associated with pain reversal and anti-inflammatory effects using zebrafish are rarely reported in the literature. This study aimed to evaluate the effect of graviola (Annona muricata L.) fruit bar (GFB) and GFB added with acerola (Malpighia glabra L) seed extract (ASE) on acute nociception and abdominal inflammation in adult zebrafish (Danio rerio). Acute nociception was induced by formalin, capsaicin, cinnamaldehyde, acidic saline, glutamate (cutaneous models), and hypertonic saline (corneal model), and inflammation was induced by carrageenan. Both GFB and ASE exhibited antinociceptive effect modulated by the nitrergic system, guanylate cyclase, and transient receptor potential ankyrin 1 and acid-sensing ion channels. The antinociceptive effect of GFB also appears to be modulated by the opioid system and glutamatergic receptors (N-methyl-D-aspartate receptor). Only ASE presented corneal antinociceptive effect. Both samples showed anti-inflammatory effect, being more significant the effect of GFB. The addition of acerola by-product extract in GFB results in a product with greater biological potential.


Subject(s)
Analgesics/pharmacology , Annona/chemistry , Anti-Inflammatory Agents/pharmacology , Inflammation/drug therapy , Nociceptive Pain/drug therapy , Animals , Behavior, Animal , Disease Models, Animal , Female , Fruit/chemistry , Male , Malpighiaceae/chemistry , Seeds/chemistry , Toxicity Tests, Acute , Zebrafish
20.
Curr Neuropharmacol ; 18(3): 202-215, 2020.
Article in English | MEDLINE | ID: mdl-31622208

ABSTRACT

Lectins are proteins or glycoproteins of non-immunological origin capable of reversibly and specifically binding to glycoconjugates. They exist in free form or associated with cells and are widely distributed in nature, being found in plants, microorganisms, and animals. Due to their characteristics and mainly due to the possibility of reversible binding to glycoconjugates, lectins have stood out as important tools in research involving Neurobiology. These proteins have the ability to modulate molecular targets in the central nervous system (CNS) which may be involved with neuroplasticity, neurobehavioral effects, and neuroprotection. The present report integrates existing information on the activity of animal and plant lectins in different areas of Neuroscience, presenting perspectives to direct new research on lectin function in the CNS, providing alternatives for understanding neurological diseases such as mental disorders, neurodegenerative, and neuro-oncological diseases, and for the development of new drugs, diagnoses and therapies in the field of Neuroscience.


Subject(s)
Brain/drug effects , Brain/metabolism , Galectins/administration & dosage , Galectins/metabolism , Plant Lectins/administration & dosage , Plant Lectins/metabolism , Animals , Humans , Neuronal Plasticity/drug effects , Neuroprotective Agents/administration & dosage , Neurosciences , Research Design
SELECTION OF CITATIONS
SEARCH DETAIL
...